Immunotherapy has dramatically improved melanoma survival rates. In this week's MedBlog, Terry Hart tells his story of surviving advanced melanoma through immunotherapy.
Melanoma rates are increasing in the U.S., even as incidences of other cancers are declining. However, treatment advances in the last decade have tripled survival rates for advanced melanoma.
The FDA approved two new drugs for the treatment of melanoma in two days, giving additional hope to patients with the deadliest form of skin cancer. Add your voice –#CallOutCancer today.